Risk factors for, and reversibility of, peripheral neuropathy associated with bortezomib-melphalan-prednisone in newly diagnosed patients with multiple myeloma: subanalysis of the phase 3 VISTA study

2010145 citationsJournal Article

Authors

Rates of bortezomib-induced PN in the frontline setting were similar to those in relapsed patients and resolved in most cases.

Good health and well-being

Published in: European Journal Of Haematology

Volume 86, Issue 1, pp. 23-31

Field-Weighted Citation Impact: 6.12